The problem of antimicrobial resistance is increasingly present and requires the discovery of
new antimicrobial agents. Although the healing features of silver have been recognized …

Cardiovascular diseases (CVDs) are a primary cause of death globally. A few classic and
hybrid treatments exist to treat CVDs. However, they lack in both safety and effectiveness …

Hydrogel-based bioadhesives have emerged as alternatives for sutureless wound closure,
since they can mimic the composition and physicochemical properties of the extracellular …

Cardiovascular diseases are the leading cause of death worldwide. Despite preventive
efforts, early detection of atherosclerosis, the common pathophysiological mechanism …

Globally, cardiovascular diseases (CVDs) are the leading cause of death and disability.
While there are many therapeutic alternatives available for the management of CVDs, the …

Cardiotoxicity, the often-overlooked second leading cause of death in cancer patients, has
been associated with certain anticancer drugs. These drugs can induce cardiac damage …

The regenerative capacity of an adult cardiac tissue is insufficient to repair the massive loss
of heart tissue, particularly cardiomyocytes (CMs), following ischemia or other catastrophic …

The adult mammalian heart possesses only limited capacity for innate regeneration and the
response to severe injury is dominated by the formation of scar tissue. Current therapy to …

Amorphous silica nanoparticle (SiNPs) has tremendous potential for a host of applications,
while its mass production, broad application and environmental release inevitably increase …

Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Heart attack and
stroke cause irreversible tissue damage. The currently available treatment options are …